Author Correction: Pericyte loss influences Alzheimer-like neurodegeneration in mice (Nature Communications, (2013), 4, 1, (2932), 10.1038/ncomms3932);Pericyte loss influences Alzheimer-like neurodegeneration in mice

Nature Communications

Volumn 4, Issue , 2013, Pages

  Sagare, Abhay P ^a   Bell, Robert D ^b   Zhao, Zhen ^a   Ma, Qingyi ^a   Winkler, Ethan A ^b   Ramanathan, Anita ^a   Zlokovic, Berislav V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; IMMUNOGLOBULIN G;

BRAIN; DISEASE INCIDENCE; DISEASE TREATMENT; GENE EXPRESSION; NERVOUS SYSTEM DISORDER; NEUROLOGY; PATHOGENICITY; PROTEIN; RODENT;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL INJURY; BRAIN PERICYTE; BRIGHT FIELD MICROSCOPY; CELL DEATH; CELL LOSS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; INTERSTITIAL FLUID; LASER DOPPLER FLOWMETRY; MICRODIALYSIS; MOUSE; NERVE DEGENERATION; NONHUMAN; VASCULAR AMYLOIDOSIS; VOLTAGE SENSITIVE DYE IMAGING; WESTERN BLOTTING;

MUS; MUS MUSCULUS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CELL DEATH; MICE; MICE, TRANSGENIC; NEURODEGENERATIVE DISEASES; NEURONS; PEPTIDE FRAGMENTS; PERICYTES; PHOSPHORYLATION; TAU PROTEINS;

EID: 84890576583     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-023-40730-y     Document Type: Erratum

References (44)

1. Armulik, A., Genove, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193-215 (2011).
2. Zlokovic, B. V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201 (2008).
3. Armulik, A. et al. Pericytes regulate the blood-brain barrier. Nature 468, 557-561 (2010).
4. Daneman, R., Zhou, L., Kebede, A. A. & Barres, B. A. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562-566 (2010).
5. Bell, R. D. et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409-427 (2010).
6. Bell, R. D. et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512-516 (2012).
7. Winkler, E. A., Bell, R. D. & Zlokovic, B. V. Central nervous system pericytes in health and disease. Nat. Neurosci. 14, 1398-1405 (2011).
8. Zlokovic, B. V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12, 723-738 (2011).
9. Marchesi, V. T. Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J. 25, 5-13 (2011).
10. Iadecola, C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5, 347-360 (2004). (Pubitemid 38568496)
11. Baloyannis, S. J. & Baloyannis, I. S. The vascular factor in Alzheimer's disease: a study in Golgi technique and electron microscopy. J. Neurol. Sci. 322, 117-121 (2012).
12. Sengillo, J. D. et al. Deficiency in mural vascular cells coincides with bloodbrain barrier disruption in Alzheimer's disease. Brain Pathol. 23, 303-310 (2013).
13. Farkas, E. & Luiten, P. G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64, 575-611 (2001). (Pubitemid 32304447)
14. Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 (2002). (Pubitemid 34790756)
15. Querfurth, H. W. & LaFerla, F. M. Alzheimer's disease. N. Engl. J. Med. 362, 329-344 (2010).
16. Benilova, I., Karran, E. & De Strooper, B. The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat. Neurosci. 15, 349-357 (2012).
17. Ballatore, C., Lee, V. M. & Trojanowski, J. Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 8, 663-672 (2007). (Pubitemid 47283144)
18. Small, S. A. & Duff, K. Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 60, 534-542 (2008).
19. Hsiao, K. et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996). (Pubitemid 26332733)
20. Spires, T. L. & Hyman, B. T. Transgenic models of Alzheimer's disease: learning from animals. NeuroRx. 2, 423-437 (2005). (Pubitemid 41444876)
21. Bell, R. D. et al. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat. Cell Biol. 11, 143-153 (2009).
22. Meyer-Luehmann, M. et al. Exogenous induction of cerebral betaamyloidogenesis is governed by agent and host. Science 313, 1781-1784 (2006). (Pubitemid 44454153)
23. Eisele, Y. S. et al. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 330, 980-982 (2010).
24. Prusiner, S. B. Cell biology. A unifying role for prions in neurodegenerative diseases. Science 336, 1511-1513 (2012).
25. Cramer, P. E. et al. ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335, 1503-1506 (2012).
26. Castellano, J. M. et al. Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Abeta clearance in a mouse model of betaamyloidosis. Proc. Natl Acad. Sci. USA 109, 15502-15507 (2012).
27. Deane, R. et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43, 333-344 (2004). (Pubitemid 39061126)
28. Wilhelmus, M. M. et al. Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells. Am. J. Pathol. 171, 1989-1999 (2007).
29. Park, L. et al. Innate immunity receptor CD36 promotes cerebral amyloid angiopathy. Proc. Natl Acad. Sci. USA 110, 3089-3094 (2013).
30. Deane, R. et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9, 907-913 (2003). (Pubitemid 36889934)
31. Davis, J. et al. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J. Biol. Chem. 279, 20296-20306 (2004). (Pubitemid 38623475)
32. Rissman, R. A. et al. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J. Clin. Invest. 114, 121-130 (2004). (Pubitemid 39071651)
33. Paul, J., Strickland, S. & Melchor, J. P. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J. Exp. Med. 204, 1999-2008 (2007). (Pubitemid 47236333)
34. Winkler, E. A., Bell, R. D. & Zlokovic, B. V. Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling. Mol. Neurodegener. 5, 32 (2010).
35. Lindahl, P., Johansson, B. R., Leveen, P. & Betsholtz, C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245 (1997). (Pubitemid 27446080)
36. Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A. & Betsholtz, C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126, 3047-3055 (1999). (Pubitemid 29378170)
37. Tallquist, M. D., French, W. J. & Soriano, P. Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development. PLoS Biol. 1, E52 (2003).
38. Deane, R. et al. IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor. J. Neurosci. 25, 11495-11503 (2005). (Pubitemid 43102486)
39. Sagare, A. P. et al. A lipoprotein receptor cluster IV mutant preferentially binds amyloid-beta and regulates its clearance from the mouse brain. J. Biol. Chem. 288, 15154-15166 (2013).
40. Farris, W. et al. Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. Am. J. Pathol. 171, 241-251 (2007). (Pubitemid 47339241)
41. Miyamoto, Y. et al. Hippocampal synaptic modulation by the phosphotyrosine adapter protein ShcC/N-Shc via interaction with the NMDA receptor. J. Neurosci. 25, 1826-1835 (2005). (Pubitemid 40279288)
42. Deane, R. et al. A multimodal RAGE-specific inhibitor reduces amyloid betamediated brain disorder in a mouse model of Alzheimer disease. J. Clin. Invest. 122, 1377-1392 (2012).
43. Deacon, R. M. Burrowing in rodents: a sensitive method for detecting behavioral dysfunction. Nat. Protoc. 1, 118-121 (2006).
44. Deacon, R. M. Assessing nest building in mice. Nat. Protoc. 1, 1117-1119 (2006).